Release Date: 23/10/15 12:31 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 771.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%